Tulane School of Medicine
Disclosure(s): AICURIS: Site PI; Gilead Sciences, Inc.: Advisor/Consultant, Site PI; Metro Biotech: Site PI; Regeneron: Site PI; The Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID): Site PI